StocksTelegraph
S&P 500NASDAQDOWRUSSELL
NASDAQ · DCTH·Healthcare

Delcath Systems, Inc. Stock Analysis & AI Score

Market Open
$16.11
Prev Close
Market Cap
Day Range
52W Range
P/E
EPS (TTM)
Volume
Avg —
Beta
69
ST Score
69.4/100B+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees
CEO
SectorHealthcare
IndustryMedical - Devices
IPO Date
Website
Country
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

DCTH
69.4out of 100
Grade B+

Delcath Systems, Inc. (DCTH) holds an ST Score of 69.4 out of 100 (B+), with its strongest factor being Profitability (A+) and its weakest Valuation (D). Analysts rate DCTH Buy across 11 ratings with a $24.50 average price target (+0.5% vs the current $16.11).

Strongest
ProfitabilityA+
Weakest
ValuationD
All factor grades
  • ProfitabilityA+
  • Financial StrengthA+
  • MomentumA
  • GrowthB+
  • ForecastB
  • ValuationD
  • Piotroski5/9
Score methodology
Press Releases

Contact

DCTH stock: frequently asked questions

What is DCTH's ST Score?

Delcath Systems, Inc. (DCTH) has an ST Score of 69.4 out of 100, an overall grade of B+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is DCTH a buy, sell, or hold?

Wall Street's consensus rating on DCTH is Buy based on 11 analyst ratings. Our own ST Score grades it B+ (69.4/100). This is data, not investment advice — always do your own research.

What is DCTH's valuation grade?

Delcath Systems, Inc. (DCTH) earns a valuation grade of D, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is DCTH's growth grade?

Delcath Systems, Inc. (DCTH) earns a growth grade of B+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is DCTH's profitability grade?

Delcath Systems, Inc. (DCTH) earns a profitability grade of A+, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is DCTH's financial strength grade?

Delcath Systems, Inc. (DCTH) earns a financial strength grade of A+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for DCTH?

The average analyst price target for Delcath Systems, Inc. (DCTH) is $24.50 from 11 analysts, which is +0.5% versus the recent price of $16.11.

What is DCTH's Piotroski score?

Delcath Systems, Inc. (DCTH) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.